EUVIMEDTutustu EUVIMEDiin
Crossref

NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy

Hai Bai, Wanqing Xu, Guozheng Wei, Yue Cao, Mingming Wang

Applied Biochemistry and Biotechnology · 2026-12 · 198 (12) · 10685-10710

DOI: 10.1007/s12010-026-05931-3 ↗

At a glance

Journal article in Applied Biochemistry and Biotechnology, published online on 2026-09-23. Written by Hai Bai and 4 co-authors. Institution: Institute of Applied Biotechnology, College of Agronomy and Life Science, Shanxi Datong University, Datong, Shanxi province, 037009, PR China. Major MEDLINE topics: Immunotherapy, Neoplasms, Biomarkers, Tumor, Nuclear Proteins. 41 references. Funded by: National Natural Science Foundation of China.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Tiivistelmää ei ole saatavilla.

Subjects

MeSH terms (MEDLINE)

ImmunotherapyNeoplasmsBiomarkers, TumorNuclear ProteinsHumansPrognosisGene Expression Regulation, Neoplastic

Author keywords

BiomarkersImmune MicroenvironmentImmunotherapyNOC4LPrognostic Marker

Substances

Biomarkers, TumorNuclear Proteins

Authors and institutions

  • Institute of Applied Biotechnology, College of Agronomy and Life Science, Shanxi Datong University, Datong, Shanxi province, 037009, PR China.
  • Department of Physiology, School of Basic Medicine and Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, PR China.
  • Xuzhou Key Laboratory of Physiological Function and Injury, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, P.R. China.
  • Department of Physiology, School of Basic Medicine and Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, PR China. wmm@xzhmu.edu.cn.
  • Xuzhou Key Laboratory of Physiological Function and Injury, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, P.R. China. wmm@xzhmu.edu.cn.
  • National Experimental Teaching Demonstration Center for Basic Medicine, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, P.R. China. wmm@xzhmu.edu.cn.

Funding

  • National Natural Science Foundation of China

Cite

APA

Bai, H., Xu, W., Wei, G., Cao, Y., & Wang, M. (2026). NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy. Applied Biochemistry and Biotechnology, 198(12), 10685-10710. https://doi.org/10.1007/s12010-026-05931-3

Vancouver

Bai H, Xu W, Wei G, Cao Y, Wang M. NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy. Applied Biochemistry and Biotechnology. 2026;198(12):10685-10710. doi:10.1007/s12010-026-05931-3

BibTeX
@article{Bai2026,
  author = {Bai, Hai and Xu, Wanqing and Wei, Guozheng and Cao, Yue and Wang, Mingming},
  title = {NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy},
  journal = {Applied Biochemistry and Biotechnology},
  year = {2026},
  volume = {198},
  number = {12},
  pages = {10685--10710},
  doi = {10.1007/s12010-026-05931-3}
}
Start for free →